HeartCore Enterprises Inc. and Heart-Tech Health deepen their partnership to integrate artificial intelligence into cardiovascular care, aiming to enhance early risk identification in women and personalised health programs. The collaboration signifies a commitment to leveraging AI for healthcare innovation and highlights the synergy between technology and healthcare sectors.
HeartCore Expands Partnership with Heart-Tech Health for AI-Enhanced Cardiovascular Platform
HeartCore Enterprises Inc., a Tokyo-based enterprise software and consulting services firm, has announced the expansion of its partnership with Heart-Tech Health to further integrate artificial intelligence (AI) into the latter’s Med-Tech platform. The collaboration aims to enhance Heart-Tech Health’s existing applications with advanced AI capabilities.
Heart-Tech Health’s flagship product, Adesso, is a Software as a Service (SaaS) platform designed to identify cardiovascular risks in women at an early stage. The software offers comprehensive risk assessments and personalized health and wellness programs. The new agreement builds upon a previous engagement with HeartCore’s subsidiary, Sigmaways, highlighting a deepening commitment to using AI to improve healthcare outcomes.
Suzanne Steinbaum, the founder and CEO of Heart-Tech Health, emphasized the significance of the partnership. “Scaling up our partnership with HeartCore is a crucial step in technologically advancing our Adesso platform,” Steinbaum said. The Adesso platform, which includes the Adesso Heart Score™ for women and MyAdesso™ for personalized health monitoring, aims to provide enhanced accessibility and early intervention in cardiovascular care.
The integration of AI is expected to refine the Adesso platform’s data processing capabilities and user experience. HeartCore’s AI Division will focus on developing specific AI applications and natural language processing tools to improve the platform’s usability and effectiveness.
HeartCore CEO Sumitaka Kanno Yamamoto expressed enthusiasm about the new contract: “I’m pleased to announce our second contract awarded to our newly established AI division. This collaboration is an example of the potential cross-selling opportunities within our broader suite of software solutions.” Yamamoto also highlighted HeartCore’s ongoing efforts to expand into U.S. markets as part of its global business strategy.
HeartCore Enterprises Inc., headquartered in Tokyo, provides enterprise software solutions, including customer experience management platforms, data analytics services, and digital transformation tools like robotics process automation and task mining. These services aim to enhance client engagement and streamline business operations.
Heart-Tech Health’s Adesso platform is gaining traction among insurers, corporate wellness programs, and value-based medical providers. It aims to reduce cardiovascular health risks among women through early detection and tailored health programs. The proprietary Adesso Heart Score™ assesses heart risk, while MyAdesso™ tracks and manages personalized health journeys. The clinical portal for providers facilitates efficient data tracking and supports a patient-focused approach to cardiovascular care.
The expansion of this partnership underscores the increasing role AI plays in healthcare innovation, particularly in improving preventive care and personalised health management. The venture also highlights the collaborative efforts between technology and healthcare sectors to create impactful solutions for persistent health challenges.
Both HeartCore Enterprises Inc. and Heart-Tech Health are committed to driving forward-looking advancements while acknowledging the uncertainties and risks inherent in pioneering new technologies. Investors and stakeholders are advised to consider these factors when evaluating the potential outcomes of such collaborations.
For further details, HeartCore Enterprises and Heart-Tech Health have provided contact points for media and investor inquiries.
